Division of Human Nutrition, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 8000, South Africa.
Infection Control Africa Network-ICAN, Cape Town 7530, South Africa.
Nutrients. 2022 Nov 3;14(21):4658. doi: 10.3390/nu14214658.
Background: The main nutritional goal for premature neonates is to achieve a postnatal growth rate that the neonate would have experienced in utero. Postnatal growth failure is, however, very common in very and extremely low birth weight neonates. The use of probiotics shows promising results in reducing the time for full feeds, as well as in increased weight gain. The optimal probiotic strain has, however, not been elucidated. The aim of the present study was to evaluate the difference in the growth and time to reach full feeds between the two treatment arms, using LabinicTM as a multi-strain probiotic and a placebo. Methods: We conducted a double-blind, placebo-controlled, randomized clinical trial investigating the effect of a multi strain probiotic (LabinicTM) on various outcomes in preterm neonates. The results on the time to reach full feeds and the growth will be discussed in this paper. A probiotic or placebo was given once daily to the neonates for 28 days. Weight and feeding volume were measured daily, and length and head circumference were measured weekly. Results: The probiotic group reached full feeds earlier 8.7 days; ± 2.0 than the placebo group 9.7 days; ±4.3 (p = 0.04) and regained their birthweight earlier than the placebo group 11.5 days ± 6.3 vs. 13.3 days ± 6.3 (p = 0.06). From day 21 onwards, the probiotic group showed a significantly greater crude gain in weight (p < 0.001) than the placebo group (estimated difference between the two groups day 21: 56.7 g and at day 28: 83.7 g. There was a significant improvement observed in the weight Z-score change in the probiotic group over the 28-day period. Conclusion: The use of a multi-strain probiotic (LabinicTM) shows great potential as a low-cost, low-risk intervention in reducing the time to reach full feeds as well as shortening the time to regain birthweight. The probiotic had an additional beneficial impact on Z-score change in weight potentially decreasing post-natal growth restriction.
早产儿的主要营养目标是实现其在子宫内本应经历的产后生长速度。然而,极低和超低出生体重儿的生长发育迟缓非常常见。益生菌的使用在减少完全喂养所需的时间以及增加体重增加方面显示出有希望的结果。然而,最佳的益生菌菌株尚未阐明。本研究的目的是评估使用 LabinicTM 作为多菌株益生菌和安慰剂在达到完全喂养的时间和生长方面的差异。
我们进行了一项双盲、安慰剂对照、随机临床试验,研究多菌株益生菌(LabinicTM)对早产儿各种结局的影响。本文将讨论达到完全喂养的时间和生长方面的结果。益生菌或安慰剂每天给予新生儿一次,持续 28 天。每天测量体重和喂养量,每周测量身长和头围。
益生菌组达到完全喂养的时间早于安慰剂组 8.7 天;±2.0 天比安慰剂组 9.7 天;±4.3(p=0.04),体重恢复时间也早于安慰剂组 11.5 天;±6.3 天比 13.3 天;±6.3(p=0.06)。从第 21 天开始,益生菌组的体重净增长明显大于安慰剂组(p<0.001)(两组在第 21 天的估计差异:56.7 克,第 28 天:83.7 克)。在 28 天的研究期间,益生菌组的体重 Z 分数变化得到了显著改善。
使用多菌株益生菌(LabinicTM)作为一种低成本、低风险的干预措施,在缩短达到完全喂养的时间以及缩短恢复出生体重的时间方面具有巨大潜力。益生菌对体重 Z 分数变化有额外的有益影响,可能降低产后生长受限。